Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
about
Glycosyltransferases and non-alcoholic fatty liver diseaseNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsPrevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in IranMultifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease.Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetesHigher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health StudyCrude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model.Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver diseaseA Randomized Controlled Trial of the Effects of an Almond-enriched, Hypocaloric Diet on Liver Function Tests in Overweight/Obese Women.Comparative Study on the Effect of Plantago psyllium and Ocimum basilicum Seeds on Anthropometric Measures in Nonalcoholic Fatty Liver Patients.Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet.Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease.Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis.Systemic Regulators of Skeletal Muscle Regeneration in Obesity.Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.The measurement of liver fat from single-energy quantitative computed tomography scans.A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.Deciphering the Relationship between Obesity and Various Diseases from a Network Perspective.Different surgical approaches in laparoscopic sleeve gastrectomy and their influence on metabolic syndrome: A retrospective study.Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation.Biliverdin Reductase and Bilirubin in Hepatic Disease.Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease.Moxibustion-Simulating Bipolar Radiofrequency Suppresses Weight Gain and Induces Adipose Tissue Browning via Activation of UCP1 and FGF21 in a Mouse Model of Diet-Induced ObesityRelationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS)Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosisHigh Fat With High Sucrose Diet Leads to Obesity and Induces Myodegeneration
P2860
Q26764913-B0E41031-7E61-4C47-95D7-EDF939304167Q26796448-461B5EAF-1038-4948-8DAA-8050B53CA853Q28079534-D55F6B59-6CBD-4C91-AE92-9A6E91D15042Q30371936-AE5195F0-C1A9-4565-94CE-502052B3AD5AQ33573638-D9569DFE-A43A-4A29-811D-9AA7E9BB8A10Q33687018-454448CA-4B69-4E43-BBB5-95E6948E622FQ33892867-9234D828-51A7-437E-B2D1-E3F8886DB29FQ35848217-8B35FC96-7B50-43A0-BDE2-6B9B30B4D526Q35982174-9782FEF0-94CD-4704-8301-5503A573B9B1Q36293897-9000E64F-7DF7-4922-A321-4011F4FC3C5DQ36656622-30656887-5F57-470E-8DC1-C0980B0E6E53Q36934465-3C0881E6-8C01-4D1E-AADB-3B72FEEB88D9Q37349823-E911E31A-5C02-49AB-8664-6E88114B2951Q37419162-8860405B-A06D-4E0A-8178-A4435A3355EDQ37563114-CE6376C3-564D-44F0-B1D4-B30961C52C34Q37634003-818EE6CA-B145-413A-8F78-B9335C242EEEQ37643941-FB686A38-1235-467E-A43A-DDF9231ED59BQ38374046-C9542AAE-AEA1-40B4-8AFA-1F86D8E7B2E6Q38622765-6D09D6A2-9390-4140-A583-D954E697212AQ39008520-1F6A0B90-32C8-44B7-8E07-F3B2FEB0EB8AQ41549432-F809192B-DC4D-43F3-8DBB-9568B6A4357EQ42669567-1C51C148-0E64-4F17-A251-40FF8AB0A051Q45305677-09BD0A92-747B-4558-A2DE-CB645A9D72AEQ47234369-684F180E-A0BD-415F-8797-FBDDE3E5D787Q47553962-A9FC288D-3365-4BF0-B9B8-A4AA04F84E71Q50696941-C2941A2C-CA4E-41E9-AD35-22036C82FE6CQ52679682-7F9F9047-84DF-4753-BABE-FFEA190D3307Q52728673-70A1557D-0B40-4ABF-A2C9-AE2269E74787Q57114390-BC0230F4-30F5-4193-8731-35561CEB778DQ57213589-135C0F91-E3E9-4B9A-889E-7E1BA1AC834EQ58570672-A91DBDA0-964E-4942-8C40-BDFB78D8BB05Q58588579-2A91BEC4-4967-4B65-B1ED-A2792E71E4B5Q58762736-CFF65F70-9241-4C5F-9B71-2EC9414A6DAA
P2860
Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@ast
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@en
type
label
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@ast
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@en
prefLabel
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@ast
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@en
P2860
P356
P1476
Non-alcoholic fatty liver dise ...... ic and clinical presentations.
@en
P2093
Davorka Lulić
Sandra Milić
P2860
P304
P356
10.3748/WJG.V20.I28.9330
P407
P50
P577
2014-07-01T00:00:00Z